These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke. Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152 [TBL] [Abstract][Full Text] [Related]
5. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. del Zoppo GJ; Higashida RT; Furlan AJ; Pessin MS; Rowley HA; Gent M Stroke; 1998 Jan; 29(1):4-11. PubMed ID: 9445320 [TBL] [Abstract][Full Text] [Related]
6. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience. Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460 [TBL] [Abstract][Full Text] [Related]
7. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543 [TBL] [Abstract][Full Text] [Related]
8. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients. Kimura K; Iguchi Y; Shibazaki K; Kobayashi K; Uemura J; Aoki J; Yamashita S; Terasawa Y; Matsumoto N J Neurol Sci; 2008 Jul; 270(1-2):48-52. PubMed ID: 18304581 [TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging characterization of hemorrhagic transformation of embolic stroke in the rat. Jiang Q; Zhang RL; Zhang ZG; Knight RA; Ewing JR; Ding G; Lu M; Arniego P; Zhang L; Hu J; Li Q; Chopp M J Cereb Blood Flow Metab; 2002 May; 22(5):559-68. PubMed ID: 11973428 [TBL] [Abstract][Full Text] [Related]
10. Early recanalization rate of major occluded brain arteries after intravenous tissue plasminogen activator therapy using serial magnetic resonance angiography studies. Kimura K; Iguchi Y; Shibazaki K; Aoki J; Uemura J Eur Neurol; 2009; 62(5):287-92. PubMed ID: 19713704 [TBL] [Abstract][Full Text] [Related]
11. Effect of the duration of middle cerebral artery occlusion on the risk of hemorrhagic transformation after tissue plasminogen activator injection in rats. Copin JC; Gasche Y Brain Res; 2008 Dec; 1243():161-6. PubMed ID: 18835259 [TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. von Kummer R; Hacke W Stroke; 1992 May; 23(5):646-52. PubMed ID: 1579960 [TBL] [Abstract][Full Text] [Related]
13. Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Brott TG; Haley EC; Levy DE; Barsan W; Broderick J; Sheppard GL; Spilker J; Kongable GL; Massey S; Reed R Stroke; 1992 May; 23(5):632-40. PubMed ID: 1579958 [TBL] [Abstract][Full Text] [Related]
14. Fibrinolytic therapy for acute embolic stroke: intravenous, intracarotid, and intra-arterial local approaches. Sasaki O; Takeuchi S; Koike T; Koizumi T; Tanaka R Neurosurgery; 1995 Feb; 36(2):246-52; discussion 252-3. PubMed ID: 7731503 [TBL] [Abstract][Full Text] [Related]
15. Intra-arterial thrombolysis using rt-PA in patients with acute stroke due to vessel occlusion of anterior and/or posterior cerebral circulation. Tountopoulou A; Ahl B; Weissenborn K; Becker H; Goetz F Neuroradiology; 2008 Jan; 50(1):75-83. PubMed ID: 17917723 [TBL] [Abstract][Full Text] [Related]
16. Investigational use of tPA in acute stroke. del Zoppo GJ Ann Emerg Med; 1988 Nov; 17(11):1196-201. PubMed ID: 3142317 [TBL] [Abstract][Full Text] [Related]
17. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. Wolpert SM; Bruckmann H; Greenlee R; Wechsler L; Pessin MS; del Zoppo GJ AJNR Am J Neuroradiol; 1993; 14(1):3-13. PubMed ID: 8427107 [TBL] [Abstract][Full Text] [Related]
18. Reduction of infarct volume by thrombolysis with rt-PA in an embolic rat stroke model. Overgaard K; Sereghy T; Boysen G; Pedersen H; Diemer NH Scand J Clin Lab Invest; 1993 Jul; 53(4):383-93. PubMed ID: 8378742 [TBL] [Abstract][Full Text] [Related]
19. An open, multicenter trial of recombinant tissue plasminogen activator in acute stroke. A progress report. The rt-PA Acute Stroke Study Group. del Zoppo GJ Stroke; 1990 Dec; 21(12 Suppl):IV174-5. PubMed ID: 2124386 [TBL] [Abstract][Full Text] [Related]
20. Improved perfusion with rt-PA and hirulog in a rabbit model of embolic stroke. Yenari MA; de Crespigny A; Palmer JT; Roberts S; Schrier SL; Albers GW; Moseley ME; Steinberg GK J Cereb Blood Flow Metab; 1997 Apr; 17(4):401-11. PubMed ID: 9143222 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]